Showing results (11-20 of 296) with videos related to
Sort By:
Pageof 30
Endocrine-Related Cancer|March 5, 2013
Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancerRhonda L Bitting, Andrew J ArmstrongThe Oncologist|August 18, 2009
Using surrogate biomarkers to predict clinical benefit in men with castration-resistant prostate cancer: an update and review of the literatureAndrew J Armstrong, Phillip G FebboThe Canadian Journal of Urology|July 16, 2005
Advanced prostate cancer: the futureAndrew J Armstrong, Michael A CarducciCurrent Opinion in Urology|May 9, 2006
New drugs in prostate cancerAndrew J Armstrong, Michael A CarducciTherapeutics and Clinical Risk Management|May 14, 2008
Satraplatin in the treatment of hormone-refractory metastatic prostate cancerAndrew J Armstrong, Daniel J GeorgeClinical Advances in Hematology & Oncology : H&O|September 17, 2005
Novel therapeutic approaches to advanced prostate cancerAndrew J Armstrong, Michael A CarducciCancer Journal (Sudbury, Mass.)|January 23, 2013
Potential predictive biomarkers for individualizing treatment for men with castration-resistant prostate cancerRhonda L Bitting, Andrew J ArmstrongUrologic Oncology|July 3, 2008
New drug development in metastatic prostate cancerAndrew J Armstrong, Daniel J GeorgeTherapeutic Advances in Urology|February 3, 2016
Tasquinimod in the treatment of castrate-resistant prostate cancer - current status and future prospectsAmit R Mehta, Andrew J ArmstrongProstate Cancer and Prostatic Diseases|October 4, 2025
Beyond PSMA: theranostic cell surface targets in metastatic prostate cancerBilal Ashraf, Jane McKenzie, Andrew J ArmstrongPageof 30